Why clinical translation cannot succeed without failure

Citations of this article
Mendeley users who have this article in their library.


The high rates of attrition that occur in drug development are widely regarded as problematic, but the failure of well-designed studies benefits both researchers and healthcare systems by, for example, generating evidence about disease theories and demonstrating the limits of proven drugs. A wider recognition of these benefits will help the biomedical research enterprise to take full advantage of all the information generated during the drug development process.




London, A. J., & Kimmelman, J. (2015). Why clinical translation cannot succeed without failure. ELife, 4(NOVEMBER2015), 1–5. https://doi.org/10.7554/eLife.12844

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free